eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells. Harnessing the latest gene-editing techniques, eGenesis’ mission is to solve the global organ shortage crisis by developing a scalable alternative to allotransplantation. eGenesis is reinvigorating the field of xenotransplantation by addressing the key virology and immunology hurdles that have prevented its advancement to date, and is developing commercially-viable products to save and improve the lives of patients who are waiting for an organ transplant.
View Top Employees from eGenesis, Inc.| Website | http://www.egenesisbio.com |
| Revenue | $12 million |
| Funding | $140 million |
| Employees | 103 (101 on RocketReach) |
| Founded | 2015 |
| Address | 300 Technology Sq, Cambridge, Massachusetts 02139, US |
| Technologies |
JavaScript,
HTML,
PHP
+28 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biopharma, Genome Engineering, Business Services, Biotechnology, Health Care, Science and Engineering, Genetics, Life Science, Medical |
| Web Rank | 4 Million |
| Competitors | CRISPR Therapeutics, Intellia Therapeutics, Inc., Synthego Corporation, System Biosciences, Twist Bioscience |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular eGenesis, Inc. employee's phone or email?
eGenesis, Inc. Questions
The eGenesis, Inc. annual revenue was $12 million in 2024.
Knut Niss is the CTO of eGenesis, Inc..
101 people are employed at eGenesis, Inc..
eGenesis, Inc. is based in Cambridge, Massachusetts.
The NAICS codes for eGenesis, Inc. are [541, 5417, 54].
The SIC codes for eGenesis, Inc. are [873, 87].
Top eGenesis, Inc. Employees
-
42
-
5+5+
-
35+
-
35+
-
21
-
55+
-
33
-
42
-
33
Related Companies
